Testosterone Enanthate
Who holds supplier records for Testosterone Enanthate? 4 organisations hold a current record for Testosterone Enanthate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Germany (1), Italy (1), India (1) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Testosterone Enanthate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/testosterone-enanthate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Testosterone Enanthate expires 4 Sept 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Testosterone Enanthate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 3391 · latest filing Oct 1978
- STEROID SPAItalyCEP Company GMP cert on recordActive DMF 32765 · latest filing Apr 2018
- SYMBIOTEC PHARMALAB PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 26166 · latest filing Jun 2012
- ASPEN OSS BVNetherlands Company GMP cert on recordActive DMF 3877 · latest filing Jun 1980
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Testosterone Enanthate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BAYER AG Leverkusen | DE | CEP 2001-155 - Rev 04 Testosterone enantate | Jul 2026 | — |
| STEROID S.P.A. Cologno Monzese | IT | CEP 2012-306 - Rev 01 Testosterone enantate | Jul 2026 | Inspected Feb 2026 Italy |
| SYMBIOTEC PHARMALAB LIMITED Indore | IN | CEP 2025-080 - Rev 00 Testosterone enantate | May 2026 | Inspected Mar 2026 Germany |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Testosterone Enanthate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDInactive DMF 27431 · filed Aug 2013
- BIOVET JOINT STOCK COInactive DMF 23920 · filed Jun 2010
- United States · Inactive DMF 4239 · filed Jun 1981
- ROUSSELL UCLAFInactive DMF 3781 · filed Apr 1980
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (6 listed products contain Testosterone Enanthate). The latest listed patent expires 4 Sept 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Testosterone Enanthate is an esterified variant of testosterone, primarily used in replacement therapy for men who have low testosterone levels. It helps maintain male health by inducing the growth and development of masculine characteristics typical of adult males.
Chemical identity
- IUPAC name
- [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
- Canonical SMILES
- CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
- InChIKey
- VOCBWIIFXDYGNZ-IXKNJLPQSA-N
- Synonyms
- Delatestryl API, androtardyl, delatestryl, nsc-17591, testosterone enantate, testosterone enanthate ciii, testosterone heptanoate, testosteroni enantas, xyosted
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Androgen
- Mechanism of action
- Androgen Receptor Agonists
- Chemical structure
- Androstanes
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Testosterone Enanthate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Testosterone Enanthate: Bayer AG (Germany), STEROID SPA (Italy), SYMBIOTEC PHARMALAB PRIVATE LTD (India) and ASPEN OSS BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Testosterone Enanthate Drug Master Files are active?
Bayer AG (DMF 3391), STEROID SPA (DMF 32765), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 26166) and ASPEN OSS BV (DMF 3877). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Testosterone Enanthate records mean?
4 organisations have only inactive Type II DMFs for Testosterone Enanthate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Testosterone Enanthate have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Testosterone Enanthate on the EDQM register, including BAYER AG Leverkusen (DE), STEROID S.P.A. Cologno Monzese (IT) and SYMBIOTEC PHARMALAB LIMITED Indore (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Testosterone Enanthate?
Yes. The latest patent listed for an approved US product containing Testosterone Enanthate expires 4 Sept 2036, across 6 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Testosterone Enanthate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Testosterone Enanthate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.